News results: "Heart Drug" |
|
 |
|
FDA Calls for New Warnings for OTC Painkillers
Over-the counter painkiller will get new labels warning consumers of the potential risks of liver...
|
FDA Extends Review of AstraZeneca, Bristol Diabetes Drug Onglyza
The Food and Drug Administration announced Thursday that it needs additional time to complete the...
|
FDA Makes Plan B Available for 17-Year-Olds without Prescription
The US Food and Drug Administration on Wednesday said it will allow 17-year-olds to get the...
|
FDA Panel Backs Bristol, AstraZeneca Diabetes Drug Onglyza
A federal panel of medical experts said Wednesday Bristol-Myers Squibb Co. and AstraZeneca...
|
Plavix-Aspirin Combo Reduces Stroke, Heart Attack Risk
Taking blood thinner Plavix along with aspirin appears to prevent stroke and heart attacks in...
|
Polypill Could Dramatically Reduce Heart Disease Risk One Day
A new five-in-one “polypil” could reduce the risk of heart attack one day, according...
|
Cholesterol Drug Crestor Reduces Risk of Vein Clots As Well
Besides reducing the incidence of heart attacks and stroke, AstraZeneca’s cholesterol drug...
|
Stents Better than Bypass Surgery at Relieving Pain
A new study presented Saturday at the American College of Cardiology conference in Orlando,...
|
New Device Shows Promise in Treating Atrial Fibrillation
A new device implanted in the heart to stop blood clots from triggering strokes (from the rhythm...
|
FDA Includes More Weight-Loss Products on Its Risk List
The Food and Drug Administration expanded its list of tainted weight loss products that consumers...
|
FDA Panel Backs Sanofi-Aventis’ Heart Drug for Approval
A panel of cardiology experts recommended Wednesday that Sanofi-Aventis experimental drug Multaq...
|
Mixing Plavix with Stomach Medicines Raises Risk of Death By 25 Percent
Mixing Bristol-Myers Squibb Co.’s anti-clotting Plavix, also known as clopidrogel, with...
|
Epilepsy Drug Zonegran Tied to Metabolic Acidosis
The US Food and Drug Administration on Monday cautioned that epilepsy drug zonisamide (Zonegran)...
|
Lilly, Daiichi Blood Thinner Prasugrel Gets European Approval
The European Commission on Monday gave its approval for blood-thinning drug Efient for heart...
|
Depart. Of Justice Seeks Damages from J&J, Scios Unit
The US Justice Department on Thursday announced its intention to join two lawsuits against a unit...
|
Drug Treating Menopausal Symptoms Linked to Breast Cancer Recurrence
A drug commonly prescribed to treat menopausal symptoms appears to increase the risk of breast...
|
FDA Approves Gout-Fighting Drug for First Time in 4 Decades
The Federal Drug Agency has approved the first gout drug in 40 years. Takeda Pharmaceuticals Co....
|
Sanofi-Aventis Waits for FDA’s Decision on Multaq (Dronedarone) Heart Drug
The FDA is expected to take a decision regarding an experimental drug from Sanofi-Aventis which is...
|
J&J’s Ablation Catheters Given Regulatory Approval for Atrial Fibrillation
People suffering from atrial fibrillation now have another way of treatment offered by...
|
February 9 - The Day Smoking Died…in Boston
Starting today, many Bostonians will breathe healthier air thanks to a tobacco ban implemented by...
|
FDA Clears J&J Catheter for Atrial Fibrillation
The US Food and Drug Administration on Friday approved Johnson & Johnson’s Navistar...
|
Panel Unanimously Votes For Lilly, Daiichi Blood Thinner Prasugrel
An advisory panel of the US Food and Drug Administration on Tuesday voted unanimously to...
|
FDA Panel Backs Ely Lilly’s Blood Thinner Prasugrel
Blood thinner prasugrel, made by Eli Lilly and Co. in a joint with Daiichi Sankyo Co., Ltd., is...
|
FDA Approves of Lilly, Daiichi Anti-Clot Drug
Friday, the Food and Drug Administration gave the go-ahead to Eli Lilly and Company’s...
|
Approval of Lilly Blood Thinner Is About To Happen
The Food and Drug Administration is reviewing the drug, called prasugrel (also known as Effient),...
|
Bisphenol A Stays in the Body Much Longer than Thought
The highly debated subject of the plastic chemical bisphenol A (BPA) is not over yet. A new study...
|
Bisphenol A Remains In Our Body Long After Intake
There has been a long debate on whether bisphenol A, an organic compound used in many food and...
|
FDA To Conduct Safety Review On Blood Thinner Plavix
The Food and Drug Administration is investigating whether blood thinner Plavix is less effective...
|
FDA Finally Approves Geron’s stem cells therapy
The Food and Drug Administration (FDA) has just tapped a Northern Californian biotech company to...
|
FDA Approves First Phase Of Stem Cells Treatment
The Food and Drug Administration (FDA) has just approved the first clinical trial using human...
|
|
 |
Specials
|
Device Prevents Stroke in Patients with Atrial Fibrillation
Researchers present Saturday at the American College of Cardiology Conference in Orlando, Florida...
|
FDA Ordered To Reconsider Restrictions on the Morning-After Pill
No matter she’s over 18 or not, every girl in the US should have access to the morning-after...
|
FDA Expands List of Risky Weight-Loss Products
Millions of people confront themselves with the No. 1 threat to their health, namely obesity....
|
BPA-Containing Baby Bottles No Longer on the US Market
Bisphenol A or BPA widely used in plastics has long been a subject of controversy among...
|
Daiichi, Lilly Get European Approval for Prasugrel
Monday, Eli Lilly & Company and Daiichi Sankyo Company announced that they had earned...
|
Medtronic’s Brain Stimulator Gets FDA Approval for OCD Patients
Patients suffering from severe obsessive-compulsive disorder that has not responded to medication...
|
Johnson&Johnson Sued by the United States
The United States has sued the Johnson&Johnson company for marketing the heart drug...
|
Bayer Agrees to Pay $20 Million to Correct Misleading Information about Its Contraceptive
Bayer HealthCare Pharmaceuticals has announced the decision to introduce a new advertising...
|
Efficacy of Bristol, Sanofi’s Plavix Questioned
The Food and Drug Administration said it has ordered the makers of the widely used blood thinner...
|
Edgar Allan Poe at the 200th Commemoration
On January 19, 1809, poet Edgar Allan Poe was born, a man who would leave an undeniable...
|
Deep Brain Stimulation: A Remedy For Parkinson’s Patients?
Deep brain stimulation improves both physical function and quality of life in...
|
Blood-Cloth Preventer Prasugrel To Be Reviewed
The U.S. Food and Drug Administration said it needs more time to review Eli Lilly and Co.'s...
|
FDA: Weight Loss Products Are Hazardous to Our Health
The holiday season is almost here and I guess you are anxious to taste everything that...
|
Hormone Therapy, Breast Cancer Recurrence, Key Issues at the Breast Cancer Symposium
A hormone therapy for breast cancer can
reduce the chances of the disease spreading by a...
|
Gene Helps Prevent Heart Disease
Some individuals who carry a gene mutation can consume fatty foods without having their cholesterol...
|
FDA Encourages Fish Consumption in Pregnant Women, Kids
Federal regulators seek to change guidelines on fish consumption for pregnant women and young...
|
Vivus’ Qnexa Proves Efficient in Obesity Trial
As more and more people fight obesity, drug makers are trying to find solutions to help them. This...
|
Study: Gene Mutation May Prevent Cardiovascular Disease
A small group of people carry a genetic mutation which helps protect their heart against the...
|
Brain-Stimulating Drugs: Should Healthy People Be Allowed to Take Them?
Should healthy people take prescription
drugs to boost their brain strength? A panel of medical...
|
Blood Pressure Drug Avapro Shows No Benefit in Heart Failure Trial
Bristol-Myers Squibb Corp. and Sanofi-Aventis SA blood
pressure drug Avapro failed in a...
|
Crestor Can Detect Risks Of Heart Attack
A cholesterol-lowering statin drug administered to people who have normal cholesterol can cut their...
|
Research Shows MP3 Player Headphones May Disrupt Pacemakers
A study publicized by U.S. researchers at an American Heart
Association meeting in New Orleans...
|
Cholesterol-Lowering Drug Crestor Benefic for Healthy People As Well
Statins of cholesterol-lowering drugs have been known to
reduce heart risk in people with...
|
“Red Wine” Drug Fights Against Obesity Regardless of Diet
Are scientists one step closer to finding the secret weapon in the fight against obesity and...
|
Avandia Risks Ban over Liver Toxicity
GlaxoSmithKline PLC’s diabetes drug faces harsh criticism as
the Washington, D.C.-based group...
|
Panel Slashes FDA over Bisphenol Safety
A panel of environmental health, toxicology and statistics
experts from three major universities,...
|
Update: Report Seriously Questions FDA Ruling On BPA Safety
An expert panel asked by the Food and Drug Administration to
review its way of handling of the...
|
Three States Urge Companies to Stop Using BPA in Baby Bottles
On Friday, attorneys
general from Connecticut, New
Jersey and Delaware
sent letters to a...
|
Learn to Avoid Energy Drinks! It’s for Your Own Good
Scientists at the Johns
Hopkins Hospitals
University are requiring
warning labels for popular...
|
Drug-Coated Stent Safer For Heart Attack Patients
A news study in the Sept. 25 issue of The New England Journal of Medicine
gives more hope to heart...
|
|
 |
Business
|
Pfizer to Focus on More Profitable Areas than Heart Disease
Tuesday, the world’s largest drugmaker, Pfizer Incorporated,
has announced it would be...
|
The US Food and Drug Administration To Take On The Tobacco Industry
Wednesday was a very important day, or one could even call it a historic day, for the tobacco...
|
Google Health Brings First Insurer Aboard
On Thursday, Blue Cross Blue Shield of Massachusetts said
it would become the first health insurer...
|
Vytorin Sales Drop for Schering and Merck, Due to Ineffectiveness
Shares of Merck and Schering-Plough dropped greatly on
Monday, after a research revealed that the...
|
Arena Pharmaceuticals’ Obesity Drug Proven Safe
Arena Pharmaceuticals Inc. announced today that its
experimental pill against obesity passed a...
|
Merck Offers 4.85 Billion Dollars To Settle Vioxx Cases
The US
drug maker Merck & Co announced on Friday it will pay 4,85 billion dollars
to settle...
|
Wal-Mart Expands $4 per Month Generic Drug Program
World’s largest retailer and the largest employer in the United States, Wal-Mart Stores Inc.,...
|
Wyeth's Lybrel Contraceptive Approved By FDA
US
Food and Drug Administration approved the first oral contraceptive designed to
stop women’s...
|
|
 |
|
| Photos Gallery |
|
|
 |
|